Tatva Chintan's IPO becomes 2021's 2nd-most subscribed issue at 180 times

Gujarat-based Tatva Chintan Pharma Chem's initial public offering (IPO) was subscribed 180.35 times at the end of the third day. It became the second-most subscribed issue of 2021 so far, overtaking Nazara Technologies' IPO which was subscribed 175.46 times. The institutional investor portion was subscribed 186.96 times, while that of non-institutional investors was subscribed 516.99 times.